Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MedWatch

Executive Summary

FDA Education and Outreach Director Mary Pat Couig and Policy & Programs Director Vicki Babb will manage MedWatch following the departure of Medical Director Stephen Goldman, MD, to Knoll Pharmaceuticals and Director Dianne Kennedy to the Office of Drug Evaluation IV (1"The Pink Sheet" Sept. 13, p. 3). FDA is searching for a permanent medical director and hopes to make that appointment before year-end

You may also be interested in...



FDA Quality Assurance Will Catalogue CDER Initiatives To Improve Processes

The Center for Drug Evaluation & Research's quality assurance unit plans to catalogue different initiatives within the center to standardize and improve processes under newly appointed Associate Director for Quality Assurance Mark Goldberger, MD.

FDA Quality Assurance Will Catalogue CDER Initiatives To Improve Processes

The Center for Drug Evaluation & Research's quality assurance unit plans to catalogue different initiatives within the center to standardize and improve processes under newly appointed Associate Director for Quality Assurance Mark Goldberger, MD.

FDA Senior Scientist Schwetz To Chair Deputy Commissioner Search Cmte.

FDA Senior Advisor for Science Bernard Schwetz, PhD, will serve as acting deputy commissioner as the agency searches for a permanent deputy for the position recently vacated by Michael Friedman, MD.

Related Content

UsernamePublicRestriction

Register

PS035141

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel